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Abstract 
 
To address the mechanism by which the human globin genes are activated 
during erythropoiesis, we have used a tiled microarray to analyse the pattern of 
transcription factor binding and associated histone modifications across the 
telomeric region of human chromosome 16 in primary erythroid and non-erythroid 
cells. This 220kb region includes the α globin genes and nine widely expressed 
genes flanking the α globin locus. This unbiased, comprehensive analysis of 
transcription factor binding and histone modifications (acetylation and 
methylation) described here not only identified all known cis-acting regulatory 
elements in the human α globin cluster but also demonstrated that there are no 
additional erythroid-specific regulatory elements in the 220kb region tested. In 
addition, the pattern of histone modification distinguished promoter elements 
from potential enhancer elements across this region. Finally, comparison of the 
human and mouse orthologous regions in a unique mouse model, with both 
regions co-expressed in the same animal, showed significant differences that 
may explain how these two clusters are regulated differently in vivo. 
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Introduction 
 
Globin gene expression plays a central role in normal erythropoiesis and 
abnormalities of globin synthesis underlie the clinically important thalassaemia 
syndromes. A long-term goal in the treatment of thalassaemia has been to 
identify ways in which to manipulate gene expression to redress the imbalance in 
α and β globin chain synthesis. Progress in this area would be enhanced by 
understanding in detail how these genes are normally regulated. To address this, 
it is important to identify all the key cis-acting sequences controlling α and β 
globin expression, the transcription factors that bind them and the accompanying 
modifications of chromatin at different stages of differentiation.  
 
To identify and characterise the cis-acting elements controlling α globin 
expression we have previously used a variety of approaches, including 
comparative genomics,
1,2 a wide range of chromatin analyses,
3,4 transgenic 
experiments,
5,6 and the analysis of expression in inter-specific hybrids.
7-9 
Upstream of the four α-like globin promoters (ζ, αD, α2 and α1) lie four multi-
species conserved sequences (MCSs) associated with erythroid-specific 
DNAse1 hypersensitive sites (HS), referred to, in human, as HS-48, HS-40, HS-
33 and HS-10 (Figure 1A). The globin genes, the upstream MCSs and several 
widely expressed flanking genes all lie within a region of conserved synteny 
spanning 130kb of the telomeric region of human chromosome 16 (16p13.3) 
(Figure 1A). Functional analyses suggest that HS-40 is the most important of the 
MCSs.
9 
 
Recently, to develop a relevant experimental system for studying human α globin 
expression and to evaluate the roles of individual elements we established a 
humanised mouse model in which the 117kb region containing the human α-like 
globin genes and all of their known regulatory elements (the α globin regulatory 
domain) completely replaces the corresponding, orthologous region of the mouse 
genome (Figure 1A).
10 Although, in this model, the human α genes are 
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expressed in an appropriate tissue- and development stage-specific manner, 
their level of expression is suboptimal (40% of that of the endogenous genes). 
This could either be because one or more critical elements in the human cluster 
have been overlooked in previous analyses or because changes in the structure 
or recognition of sequences by the key transcription factors have altered during 
evolution such that binding or stability of mouse transcription factors on human 
sequences are suboptimal. These observations prompted us to re-assess the full 
extent of the human α globin regulatory domain, and to compare, in detail, the 
binding of transcription factors and epigenetic modifications in the human and 
mouse α globin clusters during erythropoiesis. 
 
Using a tiled microarray, we used ChIP-chip technology (see “Materials and 
methods”), validated by ChIP-qPCR, to assess the binding of key erythroid 
transcription factors and characterise the associated histone modifications at 
defined stages of erythropoiesis. Applying this newly established ChIP-chip 
technology allowed us to obtain a comprehensive, unbiased analysis of the 
binding and activation of potential cis-acting sequences in a contiguous 220kb 
region of chromosome 16, extending 50kb on either side of the previously 
defined α globin regulatory domain. This demonstrated that, within this region, no 
sequences other than the known upstream regulatory elements and human α 
globin promoters bound erythroid transcription factor complexes or became 
activated (as judged by relevant histone modifications) in erythroid cells. In 
basophilic erythroblasts, when the α globin genes are fully active, a domain of 
histone H4 acetylation extending through 80kb  became established. Thus, 
together, these findings re-define the limits of the human α globin regulatory 
domain. 
 
The humanised mouse model allowed, for the first time, a direct comparison of 
transcription factor binding and chromatin modification, in heterozygotes, at the 
human and mouse loci in nuclei with identical transcriptional and epigenetic 
programmes. Using this model, and by comparing ChIP data from primary 
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human and mouse erythroid cells,
4 we identified significant differences in 
transcription factor binding and histone modification at the human and mouse 
clusters which may explain differences in their regulation.  
 
Finally the use of the tiled microarray allowed us to compare histone 
modifications across the entire α globin regulatory domain with those 
encompassing the nine widely expressed flanking genes, whose epigenetic 
profile had not previously been studied. These epigenetic marks, in combination, 
distinguish promoter elements from other classes of regulatory element (e.g. 
enhancers). 
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Materials and Methods 
 
Cells and cultures 
K562 were grown in RPMI 1640 medium (Sigma), 50 U/ml penicillin G (GIBCO), 
50 µg/ml streptomycin (GIBCO), 2 mM L-glutamine (GIBCO) supplemented with 
10% (vol/vol) foetal calf serum (PAA Laboratories GmbH, Linz, Austria). Primary 
human erythroblasts were obtained from peripheral blood mononuclear cells 
(PBMCs) collected from blood donors and expanded in a two-phase system as 
previously described.
11,12 Primary human T lymphocytes were obtained from 
PBMCs by culture for 3 days in RPMI/20% fetal calf serum in the presence of 2% 
phytohaemagglutinin M (GIBCO) and 20 U/ml interleukin-2. EBV-transformed 
lymphoblastoid cell lines were derived from normal  subjects. Mature primary 
murine erythroblasts were obtained from phenylhydrazine-treated adult 
“humanized” mice, generated as described.
10 
 
Antibodies 
The antibodies used were: anti-diacetylated histone H3 (06-599), anti-tetra-
acetylated histone H4 (06-866), anti-mono-, di- and tri-methyl Lys4 histone H3 
(07-436, 07-030, 07-473) from Upstate; RNA Pol II N20, RNA Pol II H224, NF-E2 
C19, NF-E2 p18 C16, GATA2 H-116, GATA-1 C20, GATA-1 M20, E2A.E12 V18 
from Santa Cruz Biotechnology; SCL,
13 Ldb-1 and LMO2
14 (kindly provided by C. 
Porcher) 
 
Chromatin immunoprecipitation (ChIP) assay 
ChIPs were performed according to the Upstate ChIP protocol, as described 
previously with minor modifications.
4 Cells (1,5 x 10
7 per experiment) were fixed 
with 0.4% formaldehyde for 10 minutes at room temperature and chromatin was 
sonicated to a size of less than 500 bp. Immunoprecipitations were performed, 
after an overnight incubation with the appropriate antibody, with protein A 
agarose (Upstate), or with protein G agarose (Roche) when using GATA1 
antibody. A sample containing no antibody was used as a negative control. 
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Immunoprecipitated DNA was analysed by quantitative real time PCR (qPCR) 
(ABI Prism 7000 Sequence Detection System). Primers and 5’FAM-3’TAMRA 
Taqman probes, for selected sequences of the human α globin locus (available 
on request), were designed by Primer Express software. All primers and probes 
were validated over a serial dilution of genomic DNA. For a given target 
sequence, the amount of product precipitated by a specific antibody was 
determined relative to the amount of non immunoprecipitated (input) DNA and 
these results were normalized to a control sequence in the 18S ribosomal RNA 
gene. 
 
ChIP-chip analysis 
The custom α globin tiling path microarray has been described previously.
15 450 
ng of ChIP DNA, obtained for each antibody from two independent IP reactions, 
and 450 ng of input DNA were labelled with Cy3-dCTP (Amersham) and Cy5-
dCTP (Amersham), respectively, with Bioprime Labelling system (Invitrogen). 
Labelled DNA was purified through Amersham G50 columns. ChIP-Cy3 and 
input-Cy5 DNAs were combined, precipitated in ethanol with human Cot-1 DNA 
(Invitrogen) and yeast t-RNA (Invitrogen) and re-suspended in hybridization 
buffer (50% (v/v) formamide, 2xSSC, 10mM Tris (ph7.4), 5% (w/v) dextran 
sulfate, 0.1% (v/v) Tween 20). The arrays were hybridized with the hybridization 
solution containing the labelled DNAs in a HS 400 Pro Hybridization Station 
(Tecan) for 45 hours. The arrays were then scanned in a Scan Array Gx Plus 
scanner (Perkin Elmer) and the spot intensities quantified using Scan Array 
Express Version 3.0 (Perkin Elmer) with background subtraction. The ratio of the 
background corrected ChIP signal divided by the background corrected input 
signal (both globally normalized) were used for the analysis. The data were then 
plotted and visualized on a customized genome database (GBrowse) designed 
by the Computational Biology Research Group (Oxford University). Figures 1, 3 
and 5 were generated by the GBrowse. 
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Results 
 
To study chromatin modifications and transcription factor binding throughout the 
terminal region of chromosome 16, we analysed primary human erythroblasts 
together with the human erythroid cell line K562. Primary human T lymphocytes 
or EBV transformed lymphoblastoid cell lines were studied as examples of 
differentiated, non-erythroid cells. Erythroid progenitors were derived from 
peripheral blood mononuclear cells (PBMNs) cultured through a two-phase liquid 
culture system. It has been previously shown
11,12 that circulating erythroid 
progenitors differentiate into CFU-E and terminally differentiate to erythrocytes 
after the addition of erythropoietin. Cell samples were collected on days 5, 8, 11 
and 15 of the second phase of culture. Although heterogeneous cell populations 
are present at any particular stage, clear differences in maturation are 
distinguishable (Figure 2). 
 
The pattern of histone acetylation across the terminal 220kb of human 
chromosome 16 
 
Using a ChIP-chip approach, the pattern of histone H3 and H4 acetylation (H3ac 
and H4ac) was determined across a 220 kb, telomeric region of human 
chromosome 16, including the putative α globin regulatory domain. For each 
modification we performed two biological ChIP-chip replicates using primary 
human basophilic erythroblasts (obtained at day 8 of culture, Figure 2B) and T 
lymphocytes. These duplicate analyses provided very similar profiles (data 
available for comparison at: http://www.imm.ox.ac.uk/groups/mrc_molhaem/home_pages/Higgs). 
 
By analysing chromatin from lymphocytes (Figure 1B) we detected relatively 
small peaks of H3 and H4 acetylation at the CpG islands associated with the 
promoters of the widely expressed genes that flank the α globin cluster. As 
previously noted,
3 there were very low levels of H3ac and H4ac throughout the 
inactive α globin regulatory domain. In primary adult erythroblasts (Figure 1B), 
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H3ac was enriched at the CpG islands associated with the  promoters of the 
expressed α globin genes (αD, α2 and α1), and to a lesser extent at the ζ and θ 
globin genes, which are also associated with CpG islands. Low levels of H3ac 
were also seen at all upstream MCS elements (HS-48, HS-40, HS-33 and HS-
10). By contrast, H4ac appeared more uniformly enriched at both the upstream 
elements and the active globin gene promoters, in erythroid cells.  
 
To validate these ChIP-chip data and to extend the analysis throughout erythroid 
differentiation, we carried out independent, duplicate ChIP-qPCR analyses in 
primary human erythroblasts at each stage of maturation, in T lymphocytes, and 
in the K562 cell line. The levels of H4ac and H3ac changed relatively little during 
erythroid differentiation (Supplemental Figure S1) but appeared to reach a 
maximum in basophilic erythroblasts (day 8, Figure 2B) and subsequently 
decrease. The lower levels of enrichment in the earliest stages of erythropoiesis 
could reflect the greater cellular heterogeneity in these populations. The pattern 
of acetylation observed in K562 (Supplemental Figure S1) was similar to that 
seen in primary erythroblasts, although an additional peak of acetylation was 
seen around the embryonic ζ globin gene, which is expressed in these cells. 
Moreover, in K562 the level of histone acetylation detected at HS-10 was greater 
than in primary erythroblasts, suggesting a potential role for this element in the 
regulation of embryonic gene expression.  
 
In summary, the domain of histone acetylation that appears in human erythroid 
cells extends from coordinates 92000 to 172000 and peaks of acetylation were 
seen only at previously characterised erythroid MCS elements and promoters. 
This comprehensive and extensive analysis thus provides important confirmation 
of the previously defined limits of the human α globin regulatory domain and 
established that there are no additional elements that may have been overlooked 
in the 220kb region studied. 
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The pattern of transcription factor and RNA Polymerase II binding across 
the terminal 220kb of human chromosome 16 
 
We next determined whether the activated promoters and MCS elements in the 
human  α globin cluster bound the same or similar repertoires of erythroid 
transcription factors in vivo as previously described for the mouse α globin 
cluster. We therefore performed ChIP-chip experiments for GATA1, SCL and NF-
E2 in day 8 basophilic erythroblasts (Figure 3) and ChIP-qPCR analysis for 
GATA2. No GATA2 binding was detected (data not shown), reflecting the fact 
that our analysis focussed on the later steps of erythroid differentiation when 
GATA1 expression has largely replaced GATA2. As in the mouse cluster, the 
four upstream MCS elements (HS-48, HS-40, HS-33 and HS–10) all bind 
GATA1, SCL (Figure 3) and the entire pentameric erythroid complex (data not 
shown) which includes GATA1, SCL, E2A, Lim-only 2 (LMO2) and LIM domain 
binding protein 1 (Ldb1). This complex is thought to play an important role in the 
positive regulation of erythroid-specific genes.
16-18 In addition, enrichment of both 
p45 and p18 NF-E2 subunits were observed at HS-40, and to a lesser extent, at 
HS-48. However, unlike the mouse α globin locus, no GATA1 binding was 
detected at the human α globin promoters. Furthermore, consistent with the lack 
of any DNase1 HS (DRH and MDG unpublished data) and lack of histone 
modification (Figure 1B), no transcription factor binding (GATA1, SCL and NF-
E2) was found in the orthologous region corresponding to the mouse HS-12 
element (hoHS-12). This ~250bp region of the human genome (coordinates 
Human build HG18 chr16:125635-125878) aligned maximally with the region 
corresponding to mouse HS-12, as defined by a multi-species aligment,
2 and is 
53% homologous to the mouse region. However, unlike other MCS elements it 
contains no highly conserved transcription factor binding sites and, in particular, 
no consensus GATA1 binding site. No further erythroid transcription factor 
binding was identified across the 220kb region analysed, confirming that no 
additional erythroid-specific regulatory elements were present in this region. 
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We also examined chromatin structure in the heterozygote humanised mouse 
model. In this model, the human and mouse α globin loci lie in the same nucleus 
and share an identical murine transcription factor environment. ChIP-qPCR 
analysis was performed in mature erythroid cells (Ter119+) isolated from the 
spleen of a phenylhydrazine-treated mouse. Using H4ac and H3K4me1 (see 
“Analysis of histone methylation”) antibodies, it was shown that unlike hoHS-12, 
which had only a basal level of histone acetylation and methylation (as judged by 
comparison with a non-regulatory sequence, MPG in Figure 4), HS-12 in mouse 
was modified as active chromatin. Consistent with this observation, analysis of 
transcription factor binding showed that whereas GATA1 and NF-E2 bound the 
HS-12 element in the mouse chromosome, no binding was seen at the 
corresponding region on the humanised chromosome (Figure 4). This shows 
that, even in the mouse background, there is no “cryptic” binding site at hoHS-12. 
We then tested the effect of the mouse transcription factor environment on 
GATA1 recruitment at human α globin promoters. As seen in primary human 
erythroblasts (Supplemental Figure S2), no GATA1 binding was detected at the 
human α globin promoters in this model (Figure 4). 
 
Next, we mapped RNA Polymerase II (PolII) binding throughout the terminal 
region of human chromosome 16 (Figure 3). ChIP-chip analysis using anti-PolII 
antibody showed the binding of PolII to the α globin promoters and to the 
regulatory elements HS-48 and HS-40, consistent with previous data from the 
mouse locus demonstrating the recruitment of PolII at these upstream elements 
during terminal erythroid differentiation. Although no binding was seen at HS-33 
and HS-10 in the ChIP on chip analysis, these elements do bind PolII as judged 
by qPCR (Supplemental Figure S2). 
 
Using ChIP-qPCR, we characterised the temporal association of transcription 
factors and PolII within the locus during erythroblast maturation (Supplemental 
Figure S2). The maximal enrichment of GATA1, SCL and NF-E2 occurred in the 
intermediate stages of maturation (basophilic and polychromatic erythroblasts). 
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At the later stages of erythropoiesis, GATA1 and SCL were no longer binding, 
whereas NF-E2 was still detectable at very low levels. An identical pattern of 
GATA1 and SCL complex (Ldb1, LMO2 and E2A) binding was found in K562 
cells (Supplemental Figure S3). Finally, PolII was shown to be bound at the α 
globin promoter in human erythroid cells from the first recognised stages of 
erythropoiesis and had a maximum recruitment after 8-11 days of second phase 
culture when a low enrichment was found at all the remote conserved elements 
(HS-48, HS-40, HS-33 and HS-10). 
 
Analysis of histone methylation 
 
Recent evidence suggests that cis-acting elements may not only be identified but 
may also be classified on the basis of the associated histone modifications, 
giving some insight into the role of individual elements. In fact, ChIP-chip 
analysis of 1% of human genome
19 showed that whereas most promoters of 
active genes are enriched in H3K4me3, enhancers appear to be marked by 
H3K4me1. Therefore, in addition to analysing the patterns of histone acetylation, 
we also investigated the patterns of H3K4 mono-, di-, and tri-methylation across 
the 220kb region of human chromosome 16 (Figure 5).  
 
In erythroid cells, the H3K4me1 modification was found at the upstream MCS 
elements and equally enriched at the promoters of the globin genes. No 
significant enrichment of H3K4me1 was seen at the upstream MCSs in non-
erythroid cells, whereas it was slightly enriched at all the promoters (globin and 
non-globin). H3K4me2 modified histones were clearly present at all promoters 
but not at upstream regulatory elements in non-erythroid cells. In erythroid cells 
H3K4me2 was readily detectable at the upstream elements and was further 
enriched at the globin promoters. H3K4me3 was enriched at the promoters of 
non-globin genes in non-erythroid cells and became, in comparison with the 
surrounding promoters, significantly enriched at the globin promoters only in 
erythroid cells. The level of H3K4 methylation changed relatively little during 
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erythroid differentiation (data not shown).  Therefore, consistent with a global 
analysis of these modifications,
19 H3K4me1 appears to be equally enriched at 
enhancer and promoter regions whereas H3K4me3 is more highly enriched at 
active promoters than enhancers in cells where these genes are expressed.  
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Discussion 
 
Superficially, the transcriptional and epigenetic programs controlling basic 
biological processes (e.g. erythropoiesis) appear very similar when comparing 
one mammalian species with another and the proteins involved are often 
conserved. When considering hemopoiesis, comparisons are also frequently 
extended and drawn between mammals, amphibians and fish. However, there is 
increasing evidence that the detailed mechanisms by which each species 
achieves fully regulated expression of a given gene in the context of its own 
transcriptional/epigenetic program may be quite different. 
20-22 In this case, simple 
extrapolation of mechanisms established in one species might be misleading 
when considering another. 
 
Here we have confronted this general issue by asking if the human and mouse α 
globin clusters are regulated in the same or different ways. To fully address this 
point we first needed to be sure that we have identified all of the sequences 
required for fully regulated expression of the human α cluster in the context of its 
own transcriptional/epigenetic program. Here we used a newly developed tiling 
array to comprehensively analyse the patterns of transcription factor binding and 
histone modifications across a region of 220kb of human chromosome 16 
(extending 50kb either side of the currently defined domain). Based on this study 
we can conclude that there appear to be no additional erythroid cis-elements in 
this region although we cannot formally rule out even more distant regulatory 
elements. Therefore, it seems most likely that the previously reported, sub-
optimal expression of the human α gene cluster (containing all known regulatory 
elements) in the mouse 
10 results from altered interactions, deriving from species-
specific differences between the mouse transcription factors/co-factors and the 
human cis-acting elements. In this case, fully equivalent expression of the wild 
type, human α globin cluster in a mouse transcription/epigenetic environment 
may not be achievable. 
 
For personal use only. on October 31, 2014.  by guest    www.bloodjournal.org From   15
Clearly evolution has ensured that each cluster is expressed optimally within its 
own environment. But has this process “tinkered” with the same set of 
orthologous cis-elements, have new elements been recruited, and have others 
become redundant? Evidence from other systems would suggest that all of these 
processes may be in operation.
22 Using sequence comparisons between 
erythroid cis-elements (marked by erythroid-specific DnaseI HSs) in the human 
and mouse α globin clusters there are clearly five conserved orthologous 
sequences (excluding hoHS-12 Table 1). However, these conserved regulatory 
elements appear to play different roles in each cluster. For example, removal of 
HS-40 alone from the human α globin cluster leads to a severe reduction (<5%) 
in PolII recruitment and α gene expression, whereas removal of the orthologous 
element (HS-26) in mouse causes only a moderate (~50%) decrease in 
expression.
23 It seems that another element (or elements) must normally 
contribute significant levels of α globin expression in the mouse. A comparison of 
transcription factor binding in orthologous, conserved non-coding sequences in 
mouse and human is shown in Table 1. This highlights two significant 
differences. First, whereas the mouse α globin promoter includes a consensus 
GATA sequence that is bound by GATA1 (and its co-factor ZBP, Vernimmen 
unpublished data) in vivo, the human α globin promoter does not. In fact, the α 
globin promoter, when compared in multiple, diverse mammalian species does 
not contain an evolutionarily conserved GATA site. Second, hoHS-12 is not 
marked by DnaseI HS and contains no conserved transcription factor binding 
sites corresponding to those at the mouse cis-element HS-12 (Figure 1A). In 
mouse erythroid cells, this element (like HS-40 and HS-48 in human) binds both 
the pentameric erythroid complex (GATA-1, SCL, E2A, LMO2 and Ldb-1) and 
NF-E2 and becomes activated (as judged by histone acetylation) during 
erythropoiesis. No corresponding transcription factor binding or chromatin 
activation was seen in the human, even in a mouse erythroid cell background 
(Figure 4). These observations show that the human and mouse clusters achieve 
fully regulated expression in somewhat different ways. Not only do the 
orthologous sequences play different roles in these two species but an additional, 
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species-specific element (HS-12) appears to have been recruited in the mouse 
cluster. Nevertheless, further studies will be required to define the precise role of 
this new element in vivo.  
 
Knowing which transcription factors bind each conserved sequence may help 
determine the role each sequence plays in regulating α globin expression. In 
human, natural deletions associated with α thalassaemia (which all delete HS-48 
and HS-40) show that HS-33 and HS-10 alone are not able to drive α globin 
expression whereas either HS-40, with or without HS-48, is essential.
24 This 
might be related to the fact that HS-33 and HS-10 bind only the GATA1/SCL 
complex whereas HS-48 and HS-40, bind both this complex and NF-E2 (Table 
1). Previous experiments on the β globin LCR elements have suggested that 
GATA-1 may be required to recruit PolII to such elements, but PolII is then 
transferred to the promoter in an NF-E2 dependent manner.
25,26 Thus when HS-
40 and HS-48 are deleted, PolII might be recruited to the remaining upstream 
elements (HS-33 and HS-10
27) but not transferred to the α globin promoters. 
Although the mechanism of transfer is unknown it seems most likely to involve 
physical interaction between the upstream elements and the promoters.
27 It is 
interesting to note that the additional recruited element in mouse (HS-12), which, 
together with HS-26, may subsume the role of HS-40 in human, also binds NF-
E2. 
 
The different patterns of histone modification found at the upstream elements 
and the α globin promoters may add to the previously proposed model describing 
how the upstream elements enhance α globin transcription.
27 Here, and 
elsewhere,
3 we have shown that acetylation of histone H4 is equally strong at the 
upstream elements and the promoters in erythroid cells. This could be explained 
by the recruitment of histone acetylases by specific and general DNA binding 
transcription factors at all cis-acting elements. By contrast, acetylation of histone 
H3 is much less prominent at the upstream elements than at the promoters. 
Interestingly, monomethylation of histone H3K4 (catalysed by SET7/9 histone 
For personal use only. on October 31, 2014.  by guest    www.bloodjournal.org From   17
methyltransferase
28,29) is equally enriched at the upstream elements and the 
promoters in erythroid cells. H3K4me2 (catalysed by Set1-like family of histone 
methyltransferases) is more prominent at the promoters, and H3K4me3 (also 
catalysed by Set1-like complexes
30-32) is still further enriched at the promoters 
compared with the upstream elements. It has previously been shown that 
patterns of histone H3K4 methylation may be influenced by the state of the 
associated PolII. 
33,34 In yeast, Set1 is recruited to chromatin only when the C-
terminal domain of PolII is phosphorylated at serine 5 (i.e. when activated for 
initiation of transcription).
35 In human, MLL1, homologous to yeast Set1, co-
localizes with PolII to the 5’ end of actively transcribed genes.
36 This suggests 
that the PolII recruited at the upstream elements might be inactive (and possibly 
not even engaged with DNA) and therefore the associated histones are 
predominantly modified with H3K4me1. By contrast, the PolII at the promoters is 
engaged and activated and in a state to recruit Set1 like proteins; thus, the 
associated histones are modified with H3K4me2 and H3K4me3. This implies that 
PolII may be initially recruited to the upstream elements in an inactive form and 
then transferred to the promoters where activation takes place. 
 
In conclusion, this study has demonstrated how the use of a genomic microarray 
to study in-vivo chromatin modifications may help explain some aspects of gene 
regulation at a specific locus. In addition, it has highlighted some differences in 
the mechanism of human and mouse α globin regulation which impose important 
caveats when using the mouse as a model to study human gene regulation. 
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Figure legends. 
 
Figure 1. ChIP-chip analysis of histone acetylation across 220kb of 
chromosome 16p13.3 
(A) Overview of the human α globin locus. The positions of erythroid-specific 
DHSs (eDHSs) associated with the murine MCS elements are shown at the top. 
The genes located in the telomeric region of chromosome 16p are shown. The 
red shadow box represents the putative α globin regulatory domain exchanged 
between human and mouse to produce the humanised mouse model.
10 The 
region of conserved synteny is represented as a horizontal bar. Below this, all 
CpG islands, DHSs, eDHS and multi-species conserved regulatory sequences 
(MCS-R1-4) are shown. The human eDHS corresponding to MCS-R are labelled. 
(B) H4ac and H3ac in cells collected on day 8 of the second phase of culture 
(Day 8 Ery) and in T lymphocytes (T Ly) are shown. The y axis represents 
enrichment of ChIP DNA over input DNA from one experiment. A very similar 
pattern of enrichment was seen for each biological replicate. All replicates are 
available at the website: http://www.imm.ox.ac.uk/groups/mrc_molhaem/home_pages/Higgs). The 
x axis represents the α globin locus. Grey columns run from CpG islands through 
the array data. CpG islands not represented on the array are marked with an 
asterisk. V marks CpG islands which are not associated with promoters. Dashed 
vertical lines run from mouse eDHS through the array data. 
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Figure 2. Cytospin preparations representing morphology of erythroid cells 
at different stages of the culture. 
The percentage of erythroid cells at each stage of differentiation were determined 
microscopically following May-Grünwald-Giemsa (MGG)-stained cytospins. 
Images were captured with an Olympus BX40 microscope, 40x/0.95 numerical 
aperture lens, fitted with Olympus Camedia C-3040ZOOM camera, and 
processed with Adobe Photoshop (Adobe Systems, Mountain View, CA). (A) 
Proerythroblasts (40%, black arrow) are present on day 5, although lymphocytes 
(white arrow) are the most abundant cell type. (B) Basophilic normoblasts (50%, 
arrow) are discernible on day 8. (C) Day 11 preparation demonstrates 
polychromatic erythroblasts (65%, arrow). (D) Day 15 culture shows late 
erythroblasts with pycnotic and shrunken nuclei (95%, arrow). 
 
 
For personal use only. on October 31, 2014.  by guest    www.bloodjournal.org From   26
Figure 3. ChIP-chip analysis of transcription factors and PolII across 220 kb 
of chromosome 16p13.3. 
Binding profile of GATA1 in primary erythroblasts from a homozygote 
“humanized” mouse (HM Ery), and of SCL, NF-E2 p45, NF-E2 p18 and PolII in 
day 8 human erythroblasts (Day 8 Ery) are shown. A schematic representation of 
the α globin locus is shown at the top annotated as in Figure1. Note that the 
binding profile of GATA1, is derived from “humanized” mouse, since antibodies 
recognizing human GATA1 do not perform well in ChIP assay. 
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Figure 4. ChIP-qPCR analysis in humanized mouse erythroid cells. 
H3K4me1, H4ac, GATA1 and NF-E2 p45 ChIP-qPCR analysis in Ter119+ cells 
isolated from heterozygote humanised mouse. The y axis represent average 
enrichment over input DNA from independent ChIPs, normalized to a mouse 
GAPDH control sequence. Error bars correspond to 1±SD from at least two 
independent ChIPs. Human amplicons (white columns) and mouse amplicons 
(grey columns) are indicated on the x axis. MPG, intronic sequence in MPG 
gene, α prom, α globin promoter sequence. 
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Figure 5. ChIP-chip analysis of H3K4 methylation across 220kb of 
chromosome 16p13.3. 
H3K4me1, -me2 and -me3 in cells  collected on day 8 of the second phase of 
culture (Day 8 Ery) and in EBV transformed lymphoblastoid cell lines (EBV-Ly) 
are shown. The y axis represents enrichment of ChIP DNA over input DNA from 
one experiment. A very similar pattern of enrichment was seen for each 
biological replicate. All replicates are available at the website: 
http://www.imm.ox.ac.uk/groups/mrc_molhaem/home_pages/Higgs).  A schematic representation 
of the α globin locus is shown at the top and annotated as in Figure 1. 
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Table 1. Comparison of histone modifications and transcription factor binding at the human and mouse α globin 
loci. 
 
  MCS-R1 MCS-R2 MCS-R3    MCS-R4 MCS-P9 
Human  Mouse  Human  Mouse  Human  Mouse  Human  Mouse  Human  Mouse  Human  Mouse   
HS-48 HS-31  HS-40 HS-26  HS-33 HS-21  hoHS-12  HS-12  HS-10 HS-8 
α globin 
promoter 
H4ac  ++ ++ ++ ++ ++  +++  -  ++  ++ ++ ++ ++ 
H3ac  + + + + + +  -  +  + +  ++  ++ 
H3K4me1  ++ ++ ++ ++ ++ ++  -  ++  ++ ++ ++ ++ 
H3K4me2  + + + + + +  -  +  + +  ++  ++ 
H3K4me3  - - - - - -  -  -  - -  +++  +++ 
GATA1 + + + + + +  -  +  + + -  + 
SCL  + + + + + +  -  +  + + -  - 
NF-E2  + + + + -  -  -  +  - - - - 
Pol2  + + + + + +  -  +  + +  ++++  ++++ 
 
The table summarizes ChIP results from this study and from Anguita et al
4 at erythroid-specific DHSs and α globin gene 
promoters. Differences are shown in grey shadow boxes. The multi-species conserved elements are annotated (as 
previously
2) as MCS-R1-4 (regulatory elements) and MCS-P9 (α globin promoter).  
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